ADA and acne: Accordingly, it could be concluded that the MS are an efficient carrier system for ADA and that the ADA-OPTMS-gel is competent in the targeted treatment of acne disease with plummeted side effects and systemic absorption, enhancing patient compliance compared to previously developed approaches for the delivery of adapalene.